Mus vs Sweden: Estimated antiretroviral therapy coverage among people living with HIV
Mus
36.0%
in 2025
Sweden
95.0%
in 2024
Mus rank
2nd
Sweden rank
5th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Mus
- Sweden
How they compare
Sweden currently reports 95.0% against 36.0% in Mus, a difference of 59.0%.
That makes Sweden's figure about 2.6 times Mus's.
Across all 25 years both countries report, Sweden has been ahead every year.
Mus ranks 2nd and Sweden ranks 5th of 2 regions.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mus | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.9% | 48.8% | 45.9% | Sweden |
| 2010s | 20.5% | 90.8% | 70.3% | Sweden |
| 2020s | 29.6% | 95.8% | 66.2% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Mus or Sweden?
- Sweden, at 95.0% against 36.0% in Mus as of 2024.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Mus and Sweden?
- 59.0%, with Sweden ahead.
- How many years of comparable data are there for Mus and Sweden?
- 25 years are reported by both, from 2000 to 2024.
- How do Mus and Sweden rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Mus ranks 2nd and Sweden ranks 5th of 2 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.